Drugs / AVE8112
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01803945 Comparator | Jan 2013 → Jun 2015 | Parkinson disease | Michael J. Fox Foundation for Parkinson's Research | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AVE8112 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01803945 ↗ |
| Route | Oral | “orally administered AVE8112” NCT01803945 ↗ |